Nitroxide Antioxidant Modulation of Apoptosis Genes for Autoimmune Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to effectively increase gene expression levels associated with the apoptosis pathway in human subjects, particularly those over 35 with decreased expression levels of genes like Cd5l, Perp, Unc5b, Bag5, and Bri3, which are linked to various autoimmune diseases and cancers, leading to inadequate apoptosis and increased disease risk.
Innovation Solution
Administering an effective amount of the nitroxide antioxidant 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl to human subjects, particularly those over 35 with decreased gene expression levels, to increase the expression levels of genes such as Cd5l, Perp, Unc5b, Bag5, and Bri3 in skin, adipose, and neuronal tissues.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional methods are used to treat autoimmune diseases, then disease symptoms may be temporarily managed, but gene expression levels associated with the apoptosis pathway remain decreased, leading to inadequate apoptosis and continued disease progression
Solution Approach 1:
The patent applies parameter changes by administering a nitroxide antioxidant that specifically alters the expression levels of apoptosis-associated genes (Cd5l, Perp, Unc5b, Bag5, Bri3). This changes the biological parameter of gene expression from a decreased state to an increased state, thereby restoring proper apoptotic function and treating the underlying cause of autoimmune diseases rather than merely managing symptoms
Solution Approach 2:
The nitroxide antioxidant serves as an intermediary substance that mediates between the administered treatment and the target genes. It acts as a molecular mediator that triggers increased expression of apoptosis pathway genes, thereby connecting the external treatment to the internal cellular repair mechanism without directly forcing gene expression
2Ease of operation
If gene expression levels of apoptosis pathway genes are not increased, then current treatment approaches can be maintained, but apoptosis remains inadequate, leading to increased disease risk and progression
Solution Approach 1:
The invention applies self-service by enabling the human body's own apoptotic mechanism to function properly through increased gene expression. The nitroxide antioxidant treatment restores the body's natural ability to eliminate damaged or autoreactive T cells through apoptosis, allowing the immune system to self-regulate and treat autoimmune diseases without requiring complex external intervention to directly kill pathogenic cells
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The increased gene expression levels enhance apoptosis, reducing the risk and progression of autoimmune diseases and cancers by promoting cellular homeostasis and apoptosis, thereby potentially curing or mitigating associated symptoms.
Implementation Method 1
Administering an effective amount of the nitroxide antioxidant 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl to human subjects, particularly those over 35 with decreased gene expression levels, to increase the expression levels of genes such as Cd5l, Perp, Unc5b, Bag5, and Bri3
Data Source
AI summary
A method of reducing pathogenic T-helper cell activity in a human subject in need thereof is disclosed. The method comprises administering to the human subject, known to have a condition mediated by one or more differentiated T-helper cells responsive to Cd5l, an effective amount of a nitroxide antioxidant, where the nitroxide antioxidant increases Cd5l expression, thereby reducing pathogenic T-helper cell activity. In some embodiments, the condition is an autoimmune disease.